Published in Ann Vasc Surg on November 01, 2005
Open-cell versus closed-cell stent design differences in blood flow velocities after carotid stenting. J Vasc Surg (2009) 1.58
Carotid artery stenting: current and emerging options. Med Devices (Auckl) (2014) 0.90
Carotid Wallstent placement difficulties encountered in carotid artery stenting. Springerplus (2013) 0.81
Is age of 80 years a threshold for carotid revascularization? Curr Cardiol Rev (2011) 0.77
Carotid artery stenting: what you need to know. Semin Intervent Radiol (2009) 0.75
Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg (2002) 3.35
Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery. J Vasc Surg (2007) 2.55
Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma. J Am Coll Surg (2003) 2.54
Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg (2002) 2.07
National outcomes for the treatment of ruptured abdominal aortic aneurysm: comparison of open versus endovascular repairs. J Vasc Surg (2008) 1.82
Effect of gender on long-term survival after abdominal aortic aneurysm repair based on results from the Medicare national database. J Vasc Surg (2011) 1.81
Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol (2002) 1.75
Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg (2006) 1.72
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg (2002) 1.64
Lessons learned from the analysis of gender effect on risk factors and procedural outcomes of lower extremity arterial disease. J Vasc Surg (2010) 1.61
Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm. Ann Surg (2009) 1.60
Improved outcomes are associated with multilevel endovascular intervention involving the tibial vessels compared with isolated tibial intervention. J Vasc Surg (2009) 1.57
Defining high-risk patients for endovascular aneurysm repair. J Vasc Surg (2009) 1.56
Reporting standards for thoracic endovascular aortic repair (TEVAR). J Vasc Surg (2010) 1.56
New techniques and developments to treat long infrainguinal arterial occlusions: use of reentry devices, subintimal angioplasty, and endografts. Perspect Vasc Surg Endovasc Ther (2007) 1.55
Gender trends in the repair of ruptured abdominal aortic aneurysms and outcomes. J Vasc Surg (2010) 1.54
Recurrent laryngeal nerve injury following uncomplicated carotid angioplasty and stenting. J Endovasc Ther (2009) 1.52
Endovascular management as first therapy for chronic total occlusion of the lower extremity arteries: comparison of balloon angioplasty, stenting, and directional atherectomy. J Endovasc Ther (2011) 1.50
Gadodiamide administration causes spurious hypocalcemia. Radiology (2003) 1.47
Routine early postoperative duplex scanning is unnecessary following uncomplicated carotid endarterectomy. Vasc Endovascular Surg (2002) 1.42
Outcome of elective endovascular abdominal aortic aneurysm repair in nonagenarians. J Vasc Surg (2011) 1.42
Causes and implications of readmission after abdominal aortic aneurysm repair. Ann Surg (2012) 1.39
Carotid stenting trials: what have they taught us? Perspect Vasc Surg Endovasc Ther (2010) 1.39
Endovascular treatment of an iatrogenic thoracic aortic injury after spinal instrumentation: case report. J Vasc Surg (2004) 1.39
Endovascular repair of para-anastomotic aortic aneurysms. J Vasc Surg (2007) 1.37
TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. Am J Physiol Heart Circ Physiol (2009) 1.36
Simulation improves resident performance in catheter-based intervention: results of a randomized, controlled study. Ann Surg (2006) 1.35
Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells. J Biol Chem (2009) 1.33
Identifying and grading factors that modify the outcome of endovascular aortic aneurysm repair. J Vasc Surg (2002) 1.29
Isolated iliac artery aneurysms: a contemporary comparison of endovascular and open repair. J Vasc Surg (2008) 1.27
Protein kinase C delta induces apoptosis of vascular smooth muscle cells through induction of the tumor suppressor p53 by both p38-dependent and p38-independent mechanisms. J Biol Chem (2005) 1.22
Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF. Cardiovasc Res (2009) 1.20
Outcomes of endovascular treatment of ruptured abdominal aortic aneurysms. J Vasc Surg (2006) 1.20
PKCdelta is necessary for Smad3 expression and transforming growth factor beta-induced fibronectin synthesis in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2006) 1.16
Clinical practice. Abdominal aortic aneurysms. N Engl J Med (2014) 1.15
Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation. J Vasc Surg (2009) 1.15
Insurance status predicts access to care and outcomes of vascular disease. J Vasc Surg (2008) 1.15
Endovascular repair compared with surveillance for patients with small abdominal aortic aneurysms. J Vasc Surg (2010) 1.14
The impact of increasing age on anatomic factors affecting carotid angioplasty and stenting. J Vasc Surg (2007) 1.13
Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation (2002) 1.12
Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000. J Vasc Surg (2004) 1.12
Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg (2007) 1.12
Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway. J Surg Res (2004) 1.11
TGF-β and restenosis revisited: a Smad link. J Surg Res (2011) 1.10
Computer simulation as a component of catheter-based training. J Vasc Surg (2004) 1.09
An analysis of the outcomes of a decade of experience with lower extremity revascularization including limb salvage, lengths of stay, and safety. J Vasc Surg (2010) 1.09
Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation. J Vasc Surg (2004) 1.08
PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells. J Biol Chem (2005) 1.07
Clinical competence statement on carotid stenting: training and credentialing for carotid stenting--multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on carotid interventions. J Am Coll Cardiol (2005) 1.07
Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study. J Vasc Surg (2004) 1.07
Contrast material travel times in patients undergoing peripheral MR angiography. Radiology (2002) 1.06
The cost-effectiveness of a "quick-screen" program for abdominal aortic aneurysms. Surgery (2002) 1.06
Management of endoleak after endovascular aneurysm repair: cuffs, coils, and conversion. J Vasc Surg (2003) 1.06
Statins reduce neurologic injury in asymptomatic carotid endarterectomy patients. Stroke (2013) 1.05
Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg (2008) 1.05
Current insights on the biology and clinical aspects of VEGF regulation. Vasc Endovascular Surg (2008) 1.04
A statewide experience with endovascular abdominal aortic aneurysm repair: rapid diffusion with excellent early results. J Vasc Surg (2004) 1.04
Caspase-mediated protein kinase C-delta cleavage is necessary for apoptosis of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2009) 1.02
Analysis of gender-related differences in lower extremity peripheral arterial disease. J Vasc Surg (2010) 1.01
Intimal hyperplasia--still here after all these years! Ann Vasc Surg (2004) 1.01
Protein kinase C-delta regulates migration and proliferation of vascular smooth muscle cells through the extracellular signal-regulated kinase 1/2. J Vasc Surg (2007) 1.01
Innominate artery cannulation: an alternative to femoral or axillary cannulation for arterial inflow in proximal aortic surgery. J Thorac Cardiovasc Surg (2012) 1.01
Endovascular treatment of traumatic carotid pseudoaneurysm with stenting and coil embolization. Ann Vasc Surg (2008) 1.01
Incidence of moderate to severe cognitive dysfunction in patients treated with carotid artery stenting. Neurosurgery (2009) 1.00
Protein kinase C-delta mediates adventitial cell migration through regulation of monocyte chemoattractant protein-1 expression in a rat angioplasty model. Arterioscler Thromb Vasc Biol (2012) 1.00
Type I collagen synergistically enhances PDGF-induced smooth muscle cell proliferation through pp60src-dependent crosstalk between the alpha2beta1 integrin and PDGFbeta receptor. Biochem Biophys Res Commun (2004) 1.00
Multimodal therapy for acute and chronic venous thrombotic and occlusive disease. Vasc Endovascular Surg (2005) 0.99